ArticleInfectious diseases and therapy2021

Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program.

John E Mazuski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.